Patents by Inventor Bernard L. Lerch

Bernard L. Lerch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MHC conjugates useful in ameliorating autoimmunity
    Publication number: 20030068363
    Abstract: The present invention is directed to complexes consisting essentially of an isolated MHC component and an autoantigenic peptide associated with the antigen binding site of the MHC component. These complexes are useful in treating autoimmune disease.
    Type: Application
    Filed: July 19, 2002
    Publication date: April 10, 2003
    Applicant: Anergen, Inc. a wholly-owned subsidiary of Corixa Corporation
    Inventors: Brian R. Clark, Somesh D. Sharma, Bernard L. Lerch
  • MHC conjugates useful in ameliorating autoimmunity
    Patent number: 6451314
    Abstract: The present invention is directed to complexes consisting essentially of an isolated MHC component and an autoantigenic peptide associated with the antigen binding site of the MHC component. These complexes are useful in treating autoimmune disease.
    Type: Grant
    Filed: June 23, 2000
    Date of Patent: September 17, 2002
    Assignee: Anergen, Inc.
    Inventors: Brian R. Clark, Somesh D. Sharma, Bernard L. Lerch
  • MHC conjugates useful in ameliorating autoimmunity
    Patent number: 6106840
    Abstract: The present invention is directed to complexes consisting essentially of an isolated MHC component and an autoantigenic peptide associated with the antigen binding site of the MHC component. These complexes are useful in treating autoimmune disease.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: August 22, 2000
    Assignee: Anergen, Inc.
    Inventors: Brian R. Clark, Somesh D. Sharma, Bernard L. Lerch
  • MHC class II-peptide conjugates useful in ameliorating autoimmunity
    Patent number: 5468481
    Abstract: The present invention is directed to complexes consisting essentially of an isolated MHC component and an autoantigenic peptide associated with the antigen binding site of the MHC component. These complexes are useful in treating autoimmune disease.
    Type: Grant
    Filed: April 14, 1992
    Date of Patent: November 21, 1995
    Assignee: Amergen, Inc.
    Inventors: Somesh D. Sharma, Brian R. Clark, Bernard L. Lerch